Systemic lupus erythematosus (SLE ... severe side effects and force physicians to use various drugs with other mechanisms of action. Antimalarial drugs, such as hydroxychloroquine (Plaquenil ...

Systemic lupus erythematosus (SLE ... NPSLE-like symptoms and olfactory impairment might be induced by autoimmune mechanisms that target specific areas of the brain, but this has not been explored.

A NEW Swedish study has found that menopausal hormone therapy (MHT) may be associated with an increased risk of developing ...

SLE: Systemic lupus erythematosus. Symptoms of systemic lupus erythematosus (SLE) must be brought under control to avert immediate consequences and afford the patient a better quality of life.

Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional ...

Neutropenia, a condition characterized by low neutrophil levels, is common in individuals with systemic lupus erythematosus (SLE) and can lead to severe infections ... Further research is needed to ...

July 10, 2024 — Scientists have discovered a molecular defect that promotes the pathologic immune response in systemic lupus erythematosus (known as lupus) and show that reversing this defect ...

Specific criteria for diagnosing drug-induced lupus have not been formally established. However, symptoms often overlap with those of systemic lupus erythematosus (SLE). These include: muscle and ...

Objective Metabolic reprogramming plays a critical role in modulating the innate and adaptive immune response, but its role in cutaneous autoimmune diseases, such as cutaneous lupus erythematosus (CLE ...

More information: Henry W. Chen et al, Incidence and Prevalence of Atherosclerotic Cardiovascular Disease in Cutaneous Lupus Erythematosus, JAMA Dermatology (2024). DOI: 10.1001/jamadermatol.2024.4991 ...